BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23814113)

  • 1. Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis.
    Wu SY; Huang EY; Chanchien CC; Lin H; Wang CJ; Sun LM; Chen HC; Fang FM; Hsu HC; Huang YJ
    J Radiat Res; 2014 Jan; 55(1):129-38. PubMed ID: 23814113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
    Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
    Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
    Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
    Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.
    Zhang G; Wang C; Ma C; Miao L; He F; Fu C
    Technol Cancer Res Treat; 2022; 21():15330338221141541. PubMed ID: 36426576
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
    Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting para-aortic lymph node metastases in patients with cervical cancer.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    Arch Gynecol Obstet; 2018 Aug; 298(2):381-388. PubMed ID: 29943132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
    Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    Int J Gynecol Cancer; 2018 Oct; 28(8):1584-1591. PubMed ID: 30153215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
    Yen TC; See LC; Lai CH; Tsai CS; Chao A; Hsueh S; Hong JH; Chang TC; Ng KK
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):493-501. PubMed ID: 17955238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Liu J; Tang G; Zhou Q; Kuang W
    Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy.
    Niibe Y; Nakano T; Ohno T; Suzuki Y; Oka K; Tsujii H
    Int J Gynecol Cancer; 2003; 13(6):849-55. PubMed ID: 14675323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes.
    Stryker JA; Mortel R
    Gynecol Oncol; 2000 Dec; 79(3):399-405. PubMed ID: 11104609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.